Preliminary phase II results of the CYPIDES study of ODM208 in metastatic castration-resistant prostate (mCRPC) cancer patients
Fizazi, K. Bernard-Tessier, A. Barthelemy, P. Utriainen, T. Roubaud, G. Flechon, A. van der Voet, J. C. M. Mescam, G. G. Ratta, R. Jones, R. H.
Fizazi, K.
Bernard-Tessier, A.
Barthelemy, P.
Utriainen, T.
Roubaud, G.
Flechon, A.
van der Voet, J. C. M.
Mescam, G. G.
Ratta, R.
Jones, R. H.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Fizazi K, Bernard-Tessier A, Barthelemy P, Utriainen T, Roubaud G, Flechon A, et al. Preliminary phase II results of the CYPIDES study of ODM208 in metastatic castration-resistant prostate (mCRPC) cancer patients. Annals of Oncology. 2022 Sep;33(7):S1165-S. PubMed PMID: WOS:000866211601621.